Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Filings indexed 282 across all filing types
Latest filing 2025-06-06 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during the period from June 2, 2025, to June 6, 2025. This activity directly relates to the company buying back or selling its own shares (share repurchase/issuance). This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal disclosure of this specific transaction, not just an announcement of a report.
2025-06-06 Italian
Acquisto Azioni Proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by Svas Biosana S.p.A. during the period from May 26, 2025, to May 30, 2025. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. Although it is a formal communication (Informazione Regolamentata), the specific content points directly to POS rather than a general regulatory filing (RNS). The document length is sufficient (6070 chars) to be the report itself, not just an announcement of a report.
2025-05-30 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is an official communication from Svas Biosana S.p.A. titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase). The content details the number of own shares purchased during a specific week (May 19 to May 23, 2025) and the total number of own shares held afterward. This activity directly relates to the company buying back or selling its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares' (POS). Although it is a formal communication (Informazione Regolamentata), the specific subject matter dictates the POS classification over a general RNS or RPA.
2025-05-23 Italian
Assemblea azionisti: approvazione del Bilancio 2024
AGM Information Classification · 98% confidence The document is a press release (COMUNICATO STAMPA) announcing the results of the Shareholders' Meeting (Assemblea degli Azionisti) held on May 20, 2025. The key decisions reported are the approval of the Financial Statements for the year ended December 31, 2024, and the resolution to distribute a dividend of EUR 0.25 per share. Since the document primarily reports the outcome of a shareholder vote (approval of financials and dividend distribution) which is a formal corporate action resulting from a general meeting, it strongly relates to the proceedings of that meeting. However, the core content is the approval of the annual financial statements and the subsequent dividend declaration. The dividend declaration points towards 'DIV', but the context is the formal approval by the shareholders' assembly. The most specific category covering the results of shareholder votes is 'DVA' (Declaration of Voting Results & Voting Rights Announcements). Since the document explicitly states the decisions made by the Assembly, including the dividend approval, DVA is the most appropriate classification, although 'DIV' is also relevant for the dividend part. Given the structure reporting the meeting's outcome, DVA is preferred over a simple dividend announcement (DIV) or an Annual Report (10-K) which this is not, but rather the announcement of its approval. The document also mentions that the minutes containing the voting results will be made available, reinforcing the DVA classification.
2025-05-20 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by the company (Svas Biosana S.p.A.) during a specific weekly period (May 12, 2025, to May 16, 2025). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal communication (Regulated Information No. 20240-22-2025) detailing the transaction, not just an announcement of a report.
2025-05-16 Italian
Cda esamina i ricavi consolidati al 31.03.2025
Earnings Release Classification · 98% confidence The document is a press release (COMUNICATO STAMPA) announcing that the Board of Directors (Cda) examined the consolidated revenues (ricavi consolidati) as of March 31, 2025. It provides key financial highlights, including total consolidated revenues (€ 32.7 million, +14.3% YoY) and segment breakdowns. This content structure—a brief announcement of financial results for a specific period (Q1 2025)—is characteristic of an Earnings Release (ER). It is not the full, detailed quarterly report (IR) nor the comprehensive annual report (10-K). Since it is an initial announcement of period results, ER is the most appropriate classification. Q1 2025
2025-05-09 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.